Ghoul
Member
Have you seen this in the news recently? Looks like a more affordable PCSK9 product. And should be easier to get approved for.
![]()
Leqvio's Game-Changing Potential in Cardiovascular Therapeutics and Its Implications for Novartis' Growth Trajectory
Leqvio's Game-Changing Potential in Cardiovascular Therapeutics and Its Implications for Novartis' Growth Trajectorywww.ainvest.com
If you mean Leqvio, it's been available for a little while in the US. Its main advantage is 2x shots a year vs Repatha every 2 weeks. But, it has to be done in doctors office, and reduces LDL by 50% vs Repatha 60%.
Also, because Repatha is older, despite its $7,000 list price, they've been making it available very inexpensively to insurance companies that agree to lower the pre-approval requirements.
I use Repatha, Pitavastatin 4mg, and Ezetimebe. Dropped LDL from 160 to 32, HDL increased from 40 to 53.
Finally, most important for anyone in the US, literally just a few days ago, the FDA authorized Repatha for anyone with LDL above 100 and another risk factor, like high blood pressure.
It's very easy for most people with insurance to get it now.
If anyone's interested. I'll write up the "script" you'll need to follow to get it. (you have to get around the "try a $5/mo statin first" most insurance cos still require. )


